UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | F | H | J | K | L | M | N | O | P | S | T | U | V
Number of items: 49.


Ah-See, MW; Makris, A; Taylor, NJ; Harrison, M; Ostler, PJ; Richman, PI; ... Padhani, A; + view all (2004) Changes in dynamic contrast-enhanced MRI as an early predictor of response to neoadjuvant chemotherapy in primary breast cancer. British Journal of Cancer , 91 S22 - S22.

Ah-See, MW; Padhani, AR; Taylor, NJ; Daley, FM; Bentzen, SM; Burcombe, RJ; ... Makris, A; + view all (2004) Tumour microvasculature, assessment by dynamic contrast- enhanced MRI fails to correlate with VEGF expression in breast cancer biopsies. British Journal of Cancer , 91 S16 - S16.

Arkenau, HT; Porschen, R; (2004) Adjuvante chemotherapie des kurativ resezierten kolonkarzinoms. Verdauungskrankheiten , 22 (4) 208 - 215.

Arkenau, HT; Porschen, R; (2004) Adjuvante Therapie des kolorektalen Karzinoms. Verdauungskrankheiten 208 - 215.


BBC, NO; (2004) Drug boosts lung cancer survival. UNSPECIFIED

BBC, NORCR; (2004) 'They just didn't know what it would do'. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Passive smoking is a public health hazard. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Smart drug for lung cancer tested. UNSPECIFIED

Bentzen, SM; Bernier, J; Khalil, AA; Saunders, MI; Horiot, JC; Van den Bogaert, W; ... Dische, S; + view all (2004) Estimatet effect of patient non-compliance to dose-time constraints in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Strahlentherapie und Onkologie , 180 98 - 98.

Birtle, AJ; Newby, JC; Harland, SJ; (2004) Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer. British Journal of Cancer , 91 (8) 1472 - 1476.

Bownes, P; Hoskin, PJ; Ostler, PJ; Lowe, GJ; Bryant, L; (2004) Quality assurance for fractionated high dose rate afterloading brachytherapy as monotherapy for prostate cancer. Radiotherapy and Oncology , 71 241 - ?.


Cansick, JC; Lennon, R; Cummins, CL; Howie, AJ; McGraw, ME; Saleem, MA; ... Taylor, CM; + view all (2004) Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative)glomerulonephritis. Nephrology Dialysis Transplantation , 19 2769 - 2777.

Channel, 4IMF; (2004) Happy Birthday Thalidomide. UNSPECIFIED


Dumez, H; Van Oosterom, AT; Rothermel, JD; Mull, R; Calvert, AH; (2004) Phase Ib/Il dose-escalation trial evaluating the safety and tolerability of EP0906 plus capecitabine in patients with advanced cancer. Journal of Clinical Oncology , 22 (14) 2093 - ?.


Forster, MD; Madhusudan, S; Muthuramalingam, SR; Braybrooke, JP; Wilner, S; Kaur, K; ... Harris, AL; + view all (2004) A phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor alpha Inhibitor in Patients with Metastatic Breast Cancer. Clin Cancer Res. , 10 (19) 6528 - 6534.


Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. Mutagenesis , 19 (6) 15 - ?.

Helena Selby, BBCWSABBCR4; (2004) BBC World Service Health Matters Programme on Lung Cancer. UNSPECIFIED

Hoskin, PJ; (2004) Should all breast cancer patients with symptomatic bone metastasis be treated with bisphosphonates? The case against. Clinical Oncology , 16 (2) 112 - 114.

Howie, AJ; (2004) Defining the role of pathology services in the diagnosis and staging of renal cell carcinoma. In: Aitchison, M and Oliver, RTD and Miles, A, (eds.) The Effective Management of Renal Cell Carcinoma. (49 - 53). Aesculapius Medical Press: London.

Howie, AJ; Adu, D; (2004) Different meanings of 'glomerular tip lesion'. Kidney International , 66 1716 - ?.

Huhalov, A; Spencer, DIR; Chester, KA; (2004) A strategy for characterizing antibody/antigen interactions using proteinchip arrays. In: Conn, PM, (ed.) Handbook of proteomic methods. (117 - 128). Humana Press: New Jersey.


Jia, L; Spanswick, VJ; Reid, JM; Kuffel, M; Buhrow, SA; Ames, MM; ... Tomaszewski, JE; + view all (2004) Use of the comet assay as a surrogate biomarker for the in vivo measurement of DNA damage to lymphocytes. Proceedings of the American Association for Cancer Research , 45 1969 - ?.


Kakkar, AK; Bundred, N; Carpenter, R; Makris, A; Merriman, H; Walker, ID; (2004) Venous thromboembolism in cancer patients. Guidelines. EGUIDELINES , 23 311 - 314.

Kiakos, K; Hartley, JA; Price, C; Lingerfelt, B; Handl, H; Lee, M; (2004) Design, synthesis and DNA alkylation specificity of novel achiral seco-CI-polyamide hairpin conjugates. Proceedings of the American Association for Cancer Research , 45 3091 - ?.

Kiakos, K; Mchugh, PJ; Hartley, JA; Sato, K; Summerville, K; C, L; M,; (2004) Design, synthesis and biological evaluation of AS-I-145, a novel achiral amino seco-CBI. Proceedings of the American Association for Cancer Research , 45 3998 - ?.

Kristeleit, RS; Stimson, L; Workman, P; Aherne, G; (2004) Histone modification enzymes: novel targets for cancer drugs. Expert Opinion on Emerging Drugs , 9 (1)

Kupchinsky, S; Centioni, S; Howard, T; Trzupek, J; Roller, S; Carnahan, V; ... Lee, M; + view all (2004) A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. Bioorganic and Medicinal Chemistry , 12 (23) 6221 - 6236.


Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. Mutagenesis , 19 (6) 51 - ?.

Litchfield, TM; Gilchrist, S; Sunderland, R; Folkard, M; Short, S; Prise, K; (2004) A three dimensional tissue culture model for microbeam studies. In: Proc Society for neuroscience 34th annual meeting, San Diego. (pp. P 462.4 - ?).

Liu, WM; Strauss, SJ; Chaplin, T; Shahin, S; Propper, DJ; Young, BD; ... Malpas, JS; + view all (2004) s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line. Hematol J , 5 , Article 3.


Makris, A; (2004) Critical commentary of: HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. Women's Oncology Review , 4 277 - 278.

Makris, A; (2004) Critical commentary of: Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. Women's Oncology Review , 4 213 - 214.

Makris, A; Glynne-Jones, R; Sebag-Montefiore, D; Samuel, L; Myint, S; Levine, E; ... Dixon, J; + view all (2004) Compliance to chemotherapy with oxaliplatin and 5fluorouracil in patients with advanced rectal cancer who rave received prior high-dose pelvic radiotherapy. British Journal of Cancer , 91 S34 - S34.

Mchugh, PJ; Hartley, JA; (2004) Repair of DNA interstrand crosslinks Produced by Cancer Chemotherapeutic Drugs. In: Panasci, LC and Alaoui-Jamali, MA, (eds.) DNA Repair in Cancer Therapy. (31 - 49). Humana Press: Totowa. NJ.

McMeish, I; Kanfer, EJ; Haynes, R; Giles, C; Harland, SJ; Driver, D; ... Seckl, MJ; + view all (2004) Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours. British Journal of Cancer , 90 (6) 1169 - 1175.


Novak-Hofer, I; Waibel, R; Zimmermann, K; Schibli, R; Grünberg,; J,; ... P, A; + view all (2004) Radiometal labeling of antibodies and antibody fragments for imaging and therapy. In: Methods Mol Biol. (481 - 494). Humana Press


O'Donnell, A; Judson, I; Dowsett, M; Raynaud, F; Dearnaley, D; Mason, M; ... Jarman, M; + view all (2004) Hormonal impact of the 17 alpha-hydroxylase/C-17,C-20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer. British Journal of Cancer , 90 (12) 2317 - 2325.

Okkenhaug, K; Bilancio, A; Emery, JL; Vanhaesebroeck, B; (2004) Phosphoinositide 3-kinase in T cell activation and survival. Circulation Research , 95 (4) 380 - 388.


Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed Enzyme Prodrug Therapy. In: Springer, CJ, (ed.) Suicide Gene Therapy: Methods and Protocols for Cancer. (491 - 514). Humana Press: Totowa, New Yersey.


Short, S; (2004) UNSPECIFIED In: (Proceedings) ESTRO 23, Amsterdam.

Short, SM; Makris, A; Jones, RG; Novell, R; Harrison, M; (2004) Low dose continuous hyperfractionated accelerated radiation therapy (CHART) as preoperative treatment for rectal carcinoma. British Journal of Cancer , 91 S38 - S38.

Sibtain, A; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2004) Pre-treatment haemoglobin concentration in accelerated and conventional radiotherapy for non-small cell lung carcinoma. Clinical Oncology , 16 (1) 58 - 62.

Sky, NRJJ; (2004) Cost issues behind government health reforms. UNSPECIFIED

Stewart, G; Lee, SM; (2004) Poor performance status patients and the TOPICAL Trial. Lung Cancer in Practice , 1 (3) 1 - 3.

Stewart, M; Daniell, K; Madsen, E; Le, M; Handl, H; Brooks, N; ... Lee, M; + view all (2004) Novel class of duocarmycin analogs: Design, synthesis and biological evaluation of achiral analogs of duocarmycin SA. In: Abstracts of Papers of the American Chemical Society. (pp. U29 - U29).


T M Litchfield, G; S, S; R, F; M, S; S, P; K,; (2004) UNSPECIFIED In: (Proceedings) Society for Neuroscience 34th Annual Meeting.

Taylor, CM; Chua, C; Howie, AJ; Risdon, RA; (2004) Clinico-pathological findings in haemolytic uraemic syndrome not associated with diarrhoea. Pediatric Nephrology , 19 419 - 425.


Urbaniak, MD; Bingham, JP; Hartley, JA; Woolfson, DN; Caddick, S; (2004) Improved Stability of Nitrogen-Mustard Derivatives Using apo-Neocarzinostatin. Journal of Medicinal Chemistry , 47 4710 - 4715.


Vanhaesebroeck, B; Rohn, JL; Waterfield, MD; (2004) Gene targeting: attention to detail. Cell , 118 (3) 375 - 387.

This list was generated on Sun Jun 28 04:07:38 2015 BST.